GLP-1 signaling preserves cardiac function in endotoxemic Fischer 344 and DPP4-deficient rats

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  2010-09-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00210-010-0559-9PMID 20852989
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DPP-4 Inhibition by Sitagliptin Improves the Myocardial Response to Dobutamine Stress and Mitigates Stunning in a Pilot Study of Patients With Coronary Artery Disease

  2010cited by this paper
• Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.

  2010influential reference
• Role of the glucagon-like-peptide-1 receptor in the control of energy balance.

  2010cited by this paper
• Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4

  2010cited by this paper
• The cardioprotective and inotropic components of the postconditioning effects of GLP-1 and GLP-1(9-36)a in an isolated rat heart.

  2009cited by this paper
• Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction.

  2009influential reference
• GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice

  2009cited by this paper
• Emerging cardiovascular actions of the incretin hormone glucagon‐like peptide‐1: potential therapeutic benefits beyond glycaemic control?

  2009cited by this paper
• Cardiac dysfunction in severe sepsis and septic shock

  2009cited by this paper
• Chronic inhibition of dipeptidyl peptidase-IV with ASP8497 improved the HbA1c level, glucose intolerance, and lipid parameter level in streptozotocin–nicotinamide-induced diabetic mice

  2009cited by this paper
• Decreased dipeptidyl peptidase-IV activity and glucagon-like peptide-1(7-36)amide degradation in type 2 diabetic subjects.

  2008cited by this paper
• Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways

  2008cited by this paper
• Dipeptidyl peptidase IV inhibitors in diabetes: more than inhibition of glucagon-like peptide-1 metabolism?

  2008cited by this paper
• DPP4 Inhibitors: a new approach in diabetes treatment

  2008influential reference
• DPP4 inhibitors for diabetes--what next?

  2008cited by this paper
• Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study

  2008cited by this paper
• High-Dose Folic Acid Pretreatment Blunts Cardiac Dysfunction During Ischemia Coupled to Maintenance of High-Energy Phosphates and Reduces Postreperfusion Injury

  2008influential reference
• Vasopressor use in septic shock: an update

  2008cited by this paper
• Pharmacological profile of ASP8497, a novel, selective, and competitive dipeptidyl peptidase-IV inhibitor, in vitro and in vivo

  2008cited by this paper
• MITOCHONDRIAL DYSFUNCTION, BIOENERGETIC IMPAIRMENT, AND METABOLIC DOWN-REGULATION IN SEPSIS

  2007cited by this paper
• CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders.

  2007cited by this paper
• Mechanisms of Disease: Toll-like receptors in cardiovascular disease

  2007cited by this paper
• Stress, NPY and vascular remodeling: Implications for stress-related diseases.

  2007cited by this paper
• Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure.

  2006cited by this paper
• Management of sepsis.

  2006cited by this paper
• Severe sepsis and septic shock: review of the literature and emergency department management guidelines.

  2006cited by this paper
• Right and left ventricular function after chronic pulmonary artery banding in rats assessed with biventricular pressure-volume loops.

  2006cited by this paper
• The biology of incretin hormones.

  2006cited by this paper
• Glucagon-like peptide-1 inhibits LPS-induced IL-1beta production in cultured rat astrocytes.

  2006cited by this paper
• Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy.

  2005cited by this paper
• Increased leakage of sarcoplasmic reticulum Ca2+ contributes to abnormal myocyte Ca2+ handling and shortening in sepsis*

  2005cited by this paper
• Cytokine-Induced Modulation of Cardiac Function

  2004cited by this paper
• Neuropeptide Y stabilizes body temperature and prevents hypotension in endotoxaemic rats

  2004influential reference
• Recombinant Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake and Improves Left Ventricular Performance in Conscious Dogs With Pacing-Induced Dilated Cardiomyopathy

  2004cited by this paper
• Stress-hyperglycemia, insulin and immunomodulation in sepsis

  2004cited by this paper
• Enhanced glucose‐dependent glucagon‐like peptide‐1 and insulin secretion in Crohn patients with terminal ileum disease is unrelated to disease activity or ileal resection

  2004cited by this paper
• Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum.

  2004cited by this paper
• Effects of in Vivo Lipopolysaccharide Infusion on Vasoconstrictor Function of Rat Isolated Mesentery, Kidney, and Aorta

  2003cited by this paper
• The multifunctional or moonlighting protein CD26/DPPIV.

  2003cited by this paper
• Novel strategies for the treatment of sepsis

  2003cited by this paper
• Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?

  2003cited by this paper
• Somatostatin-28 regulates GLP-1 secretion via somatostatin receptor subtype 5 in rat intestinal cultures.

  2002cited by this paper
• Prognostic value of dobutamine stress test in patients with septic shock.

  2001cited by this paper
• Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum.

  2000cited by this paper
• Sarco(endo)plasmic reticulum calcium pumps: recent advances in our understanding of structure/function and biology (Review)

  2000cited by this paper
• Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26.

  2000cited by this paper
• Nitric oxide in sepsis and endotoxaemia.

  1998cited by this paper
• The structure and function of CD26 in the T‐cell immune response

  1998cited by this paper
• Alteration by lipopolysaccharide of the relationship between intracellular calcium levels and contraction in rat mesenteric artery

  1996cited by this paper
• Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum

  1996cited by this paper
• Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide.

  1995cited by this paper
• Neuropeptide Y infusion improves hemodynamics and survival in rat endotoxic shock.

  1993influential reference
• Myocardial beta adrenergic receptor coupling to adenylate cyclase during developing septic shock.

  1990influential reference
• Myocardial beta adrenergic receptor coupling to adenylate cyclase during developing septic shock.

  1990cited by this paper
• Management of Sepsis

  1960cited by this paper

• Hyperglycemia in sepsis.

  2025cites this paper
• GLP-1 as a regulator of sepsis outcomes: Insights into cellular metabolism, inflammation, and therapeutic potential.

  2025cites this paper
• GLP-1 receptor agonists and hospitalization due to infections in patients with type 2 diabetes: A nationwide cohort study.

  2025cites this paper
• GLP-1 RAs and Cardiovascular and Kidney Outcomes by Body Mass Index in Type 2 Diabetes

  2025cites this paper
• GLP-1 receptor agonists: exploration of transformation from metabolic regulation to multi-organ therapy

  2025cites this paper
• Screening of novel disease genes of sepsis-induced myocardial Disfunction by RNA sequencing and bioinformatics analysis.

  2024cites this paper
• Delta 9-tetrahydrocannabinol conserves cardiovascular functions in a rat model of endotoxemia: Involvement of endothelial molecular mechanisms and oxidative-nitrative stress

  2023cites this paper
• Effects of GLP-1 receptor agonists on arrhythmias and its subtypes in patients with type 2 diabetes: A systematic review and meta-analysis

  2022influential citation
• GLP-1 Receptor: A New Target for Sepsis

  2021cites this paper
• GLP-1 Analog Liraglutide Improves Vascular Function in Polymicrobial Sepsis by Reduction of Oxidative Stress and Inflammation

  2021cites this paper
• Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression

  2021cites this paper
• A suggestion of using Ang-(1-7) and/or GLP-1 receptor agonists in high mortality patients with COVID-19

  2020cites this paper
• COVID-19 and the Heart and Vasculature

  2020cites this paper
• Novel approaches to reduce virus-induced inflammation in patients with cardiovascular disease

  2020cites this paper
• A novel isoquinoline derivative exhibits anti-inflammatory properties and improves the outcomes of endotoxemia

  2019cites this paper
• Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease

  2019cites this paper
• Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis

  2018cites this paper
• Time Response of Oxidative/Nitrosative Stress and Inflammation in LPS-Induced Endotoxaemia—A Comparative Study of Mice and Rats

  2017cites this paper
• Overexpression of GLP-1 receptors suppresses proliferation and cytokine release by airway smooth muscle cells of patients with chronic obstructive pulmonary disease via activation of ABCA1.

  2017cites this paper
• Glucagon‐like peptide‐1 receptor signalling reduces microvascular thrombosis, nitro‐oxidative stress and platelet activation in endotoxaemic mice

  2017cites this paper
• Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors

  2017influential citation
• Modification of Caffeic Acid with Pyrrolidine Enhances Antioxidant Ability by Activating AKT/HO-1 Pathway in Heart

  2016cites this paper
• Systemic effects Improved glucose metabolism Increased vasodilation Inflammatory cells Weight loss Blood pressure decrease Reduction of atherosclerotic lesions Liver and pancreas

  2015cites this paper
• TM-1-1DP exerts protective effect against myocardial ischemia reperfusion injury via AKT-eNOS pathway

  2015cites this paper
• Gliptin and GLP‐1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide‐induced endotoxemia

  2015cites this paper
• Exploiting the Pleiotropic Antioxidant Effects of Established Drugs in Cardiovascular Disease

  2015cites this paper
• DPP4 Deficiency Preserved Cardiac Function in Abdominal Aortic Banding Rats

  2014influential citation
• Can Sitaglipten Attenuate Hypertension, Myocardial Changes and Vascular Reactivity Induced by Long Term Blockade of Nitric Oxide Synthesis in the Rat?

  2014cites this paper
• The potential for renoprotection with incretin-based drugs.

  2014cites this paper
• The potential for renoprotection with incretin-based

  2014cites this paper
• GLP-1 Secretion Is Increased by Inflammatory Stimuli in an IL-6–Dependent Manner, Leading to Hyperinsulinemia and Blood Glucose Lowering

  2014cites this paper
• GLP-1 receptor agonists: effects on cardiovascular risk reduction.

  2013cites this paper
• Glucagon-like peptide-1 (GLP-1) reduces mortality and improves lung function in a model of experimental obstructive lung disease in female mice.

  2013cites this paper
• DPP4 Deficiency Exerts Protective Effect against H2O2 Induced Oxidative Stress in Isolated Cardiomyocytes

  2013cites this paper
• Glucagon-like peptide 1 and cardiac cell survival.

  2012cites this paper
• Kardiovaskuläre Effekte inkretinbasierter Therapien

  2012cites this paper
• Dipeptidyl peptidase 4 inhibition increases myocardial glucose uptake in nonischemic cardiomyopathy.

  2012cites this paper
• Renal and Cardiac Effects of DPP4 Inhibitors – from Preclinical Development to Clinical Research

  2012cites this paper
• The effect of glucagon-like peptide 1 on cardiovascular risk

  2012cites this paper
• Glucagon-like peptide 1 and cardiac cell survival

  2012cites this paper
• Péptido similar al glucagón tipo 1 y supervivencia de la célula cardiaca

  2012cites this paper
• GLP-1 and cardioprotection: from bench to bedside.

  2012influential citation
• Cardiovascular effects of incretin-based therapies.

  2011cites this paper
• Glucagon‐like peptide‐1‐based therapies and cardiovascular disease: looking beyond glycaemic control

  2011cites this paper
• DPP4 deficiency preserves cardiac function via GLP-1 signaling in rats subjected to myocardial ischemia/reperfusion

  2011influential citation
• Effects of DPP-4 Inhibitors on the Heart in a Rat Model of Uremic Cardiomyopathy

  2011cites this paper